The SARS-CoV2 and mitochondria: the impact on cell fate.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
11 05 2022
Historique:
received: 26 07 2020
accepted: 27 06 2021
entrez: 12 5 2022
pubmed: 13 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Coronavirus infection causes endoplasmic reticulum stress inside the cells, which inhibits protein folding. Prolonged endoplasmic reticulum stress causes an apoptotic process of unfolded protein response-induced cell death. Endoplasmic reticulum stress rapidly induces the activation of mTORC1, responsible for the induction of the IRE1-JNK pathway. IRE1-JNK stands out for its dual nature: pro-apoptotic in the first stage of infection, anti-apoptotic in persistently infected cells. Once penetrated the cells, the virus can deflect the mitochondrial function by implementing both waterfalls pro-apoptotic and anti-apoptotic response. The virus prevents, through Open Reading Frame 9b (ORF-9b) interacting with mitochondria, the response of the type I interferon of the cells affected by the infection and is fundamental for generating an antiviral cellular state. ORF-9b has effects on mitochondrial dynamics, inducing fusion and autophagy and promoting cell survival. The recognition of ORF-9b has made it possible to identify it as a molecular target of some existing potentially effective drugs (Midostaurin and Ruxolitinib). Other drugs, with the same target, are currently being tested. Given the great importance of mitochondria in virus-host interaction, in-depth knowledge of the actors and pathways involved is essential to continue developing new therapeutic strategies against SARS CoV2.

Identifiants

pubmed: 35546040
doi: 10.23750/abm.v93i2.10327
pmc: PMC9171887
doi:

Substances chimiques

RNA, Viral 0
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2022199

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2000 Jan 28;287(5453):664-6
pubmed: 10650002
J Virol. 2012 Nov;86(21):11745-53
pubmed: 22915798
Cell. 2006 Jun 30;125(7):1241-52
pubmed: 16814712
Stem Cells Int. 2017;2017:1826746
pubmed: 29158738
Biochim Biophys Acta. 2005 Jun 30;1741(1-2):4-10
pubmed: 15916886
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
J Virol. 1980 Jan;33(1):449-62
pubmed: 6245243
Nat Rev Mol Cell Biol. 2008 Mar;9(3):231-41
pubmed: 18073771
J Virol. 2007 Nov;81(22):12323-36
pubmed: 17855519
Front Microbiol. 2014 Jun 17;5:296
pubmed: 24987391
J Biochem. 2007 Feb;141(2):137-45
pubmed: 17190786
bioRxiv. 2020 Mar 22;:
pubmed: 32511329
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10190-5
pubmed: 21646527
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Nature. 2013 Aug 8;500(7461):227-31
pubmed: 23831647
Virus Res. 2014 Dec 19;194:110-23
pubmed: 25304691
J Cell Biol. 1994 Jan;124(1-2):55-70
pubmed: 8294506
Int J Cell Biol. 2014;2014:467452
pubmed: 24899897
Nat Immunol. 2009 Dec;10(12):1300-8
pubmed: 19881509
Nucleic Acids Res. 2016 Sep 6;44(15):7007-78
pubmed: 27436286
Viruses. 2012 Nov 30;4(12):3440-51
pubmed: 23202545
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Microbes Infect. 2019 Jan - Feb;21(1):20-32
pubmed: 29953921
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Panminerva Med. 2020 May 20;:
pubmed: 32432445
PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Nature. 1991 Dec 12;354(6353):494-6
pubmed: 1749429
Nat Cell Biol. 2011 Mar;13(3):184-90
pubmed: 21364565
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Traffic. 2009 Jun;10(6):673-90
pubmed: 19302420
Hum Mol Genet. 2009 Oct 15;18(R2):R169-76
pubmed: 19808793
Annu Rev Genet. 2005;39:359-407
pubmed: 16285865
Respirology. 2018 Feb;23(2):130-137
pubmed: 29052924
J Virol. 2004 Aug;78(15):7863-6
pubmed: 15254158
Mol Cell Biol. 1999 Dec;19(12):8469-78
pubmed: 10567572
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
J Virol. 2005 Feb;79(4):2079-86
pubmed: 15681410
EMBO Rep. 2010 Feb;11(2):133-8
pubmed: 20019757
Am J Respir Cell Mol Biol. 2013 Jun;48(6):742-8
pubmed: 23418343
J Biol Chem. 2006 Feb 10;281(6):3198-203
pubmed: 16339146
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
J Virol. 2009 Jul;83(13):6522-33
pubmed: 19369352
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
J Clin Med. 2020 Apr 01;9(4):
pubmed: 32244779
Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2822-33
pubmed: 25595529
J Virol. 2000 Feb;74(3):1393-406
pubmed: 10627550
PLoS One. 2009 Jul 02;4(7):e6130
pubmed: 19572016
J Virol. 2007 Jan;81(1):20-9
pubmed: 16928755
J Virol. 2006 Jun;80(12):5927-40
pubmed: 16731931
Mol Cell Biol. 2006 Dec;26(24):9220-31
pubmed: 17030611
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364

Auteurs

Eleonora Madeddu (E)

School of Pediatrics, University of Cagliari, Italy. dreleonoramadeddu@gmail.com.

Barbara Maniga (B)

School of Pediatrics, University of Cagliari, Italy. barbaramaniga@gmail.com.

Marco Zaffanello (M)

University of Verona. marco.zaffanello@univr.it.

Vassilios Fanos (V)

School of Pediatrics, University of Cagliari, Italy. vafanos@tiscali.it.

Antonietta Marcialis (A)

School of Pediatrics, University of Cagliari, Italy. ma.marcialis@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH